316 results
Page 3 of 16
6-K
EX-99.1
eb70g0
7 Oct 22
Notice of Annual General Meeting
3:06pm
6-K
EX-99.2
k9awm9 gtdzuxerp
29 Aug 22
Current report (foreign)
4:00pm
6-K
EX-5.1
ip1802
19 Aug 22
Current report (foreign)
10:54am
424B5
7tldi686no
19 Aug 22
Prospectus supplement for primary offering
10:52am
6-K
EX-99.1
dbn l9knk
1 Aug 22
Current report (foreign)
4:48pm
6-K
EX-2.1
pfqlvmjxn6 x1ua9s1
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-10.3
4mephi209lgawo uw9b
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-2.1
hjuu4djp7ow09ke8ov
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-99.1
aoojk ugl
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am
20-F/A
xz8h4gp1jw
3 Mar 22
Annual report (foreign) (amended)
6:57pm
20-F/A
EX-15.1
uvwbpub4
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
EX-99.2
fphf3
25 Feb 22
Current report (foreign)
5:29pm
UPLOAD
73wcoc7 8eq6yfvaeisp
17 Feb 22
Letter from SEC
12:00am
6-K
EX-99.2
9bfsnvr5whm34in4ll
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.2
42cg17wo97g6uqb9tpn6
30 Aug 21
Current report (foreign)
5:21pm